Creative Planning’s Artiva Biotherapeutics ARTV Stock Holding History

Creative Planning’s Portfolio ARTV Stock Details ARTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$81K	Buy	+11,372	New	+$115K	﹤0.01%	4154

Other funds holding ARTV

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Creative Planning's ARTV Position: Q3 2026 in Review

Creative Planning opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 11,372 shares worth $81K. The stake represents ﹤0.01% of the portfolio and ranks #4154 among its holdings.

12 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

Creative Planning held 11,372 shares of Artiva Biotherapeutics worth $81K as of Q3 2026.
Artiva Biotherapeutics was a new Creative Planning position in Q3 2026.
Artiva Biotherapeutics made up ﹤0.01% of Creative Planning's portfolio in Q3 2026, its #4154 holding.
12 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.